Pure Global
NCT05798377

Maternal Stress and Blood Sugar Metabolization

Maternal Stress and Blood Sugar Metabolization During Pregnancy
Sanford Health·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Pregnancy
Study type
Observational
Sponsor & location
Primary sponsor
Sanford Health
Location
Sioux Falls, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 31, 2023
End date
Sep 30, 2025
Enrollment
150 participants
Primary outcome

Oral Glucose Tolerance Test

Summary

During pregnancy, gestational diabetes increases the risk of complications and adverse
 outcomes for mother and child, however about 50% of gestational diabetes cases are diagnosed
 without a known risk factor present. This project uses both a large sample retrospective
 study, and a prospective study to help us understand the mechanisms by which mental health
 and stress impact glucose metabolization during pregnancy and delineate their contribution to
 gestational diabetes and racial disparities. The investigators expect, to improve the ability
 to identify women at risk, and advance options for preventative care and treatment,
 decreasing the impact of gestational diabetes and related complications.

ICD-10 classifications
Pregnancy confirmedPregnancy-related condition, unspecifiedAbdominal pregnancyPregnancy, not (yet) confirmedOvarian pregnancy
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05798377
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05798377 through Pure Global AI's free database. This phase not specified trial is sponsored by Sanford Health and is currently Recruiting. The study focuses on Pregnancy. Target enrollment is 150 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.